Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Zomacton® (somatropin) – Expanded indication
January 31, 2018 - Ferring Pharmaceuticals announced the FDA approval of Zomacton (somatropin), for the replacement of endogenous growth hormone (GH) in adults with GH deficiency (GHD).
